Invesaro

Stocks KLRA Earnings

Earnings

Kailera Therapeutics, Inc. (KLRA) earnings

Quarterly results of Kailera Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 6 quarters, the latest results release and when the next one is expected.

Free, no password. An email when KLRA files with the SEC.

Next earnings date

Kailera Therapeutics, Inc. is expected to report around January 25, 2027. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.

Latest quarter: Q3 FY2026

In Q3 FY2026 (ended September 30, 2026) Kailera Therapeutics, Inc. reported revenue of - and a net loss of $95.7M.

Diluted earnings per share were -$0.74.

Filed with the SEC on November 4, 2026.

Net income by quarter
Q1 26: -$18M -$18M Q1 26Q2 26: -$28.9M -$28.9M Q2 26Q3 26: -$39.6M -$39.6M Q3 26Q1 26: -$78.9M -$78.9M Q1 26Q2 26: -$111.3M -$111.3M Q2 26Q3 26: -$95.7M -$95.7M Q3 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q3 FY2026September 30, 2026---$95.7M-$0.74
Q2 FY2026June 30, 2026---$111.3M-$1.09
Q1 FY2026March 31, 2026---$78.9M-$3,650.00
Q3 FY2026September 30, 2025---$39.6M-$39,623.00
Q2 FY2026June 30, 2025---$28.9M-$28,947.00
Q1 FY2026March 31, 2025---$18M-$17,983.00

Results filings

When is Kailera Therapeutics, Inc.'s next earnings date?

Kailera Therapeutics, Inc. is expected to report around January 25, 2027. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.

Get an email when KLRA reports

Follow KLRA and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when KLRA files with the SEC.

Source: quarterly figures Kailera Therapeutics, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Kailera Therapeutics, Inc.